Conferences - Results from #11700

EAU 2011 - A negative multi-parametric MRI can rule out up to 97% of clinically significant prostate cancer - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - The objective of this study was to evaluate a role for multi-parametric MRI (mp-MRI) in ruling-out clinically significant prostate cancer.

EAU 2011 - Exponential PSA trends predict the risk of high Gleason cancer two years into the future for a screening population - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - The study hypothesis was that trends in PSA could predict future risk of high Gleason score prostate cancer (CaP) and justify low PSA thresholds for high PSA growth rates.

EAU 2011 - Impact of surgical technique (open vs. laparoscopic vs. robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: An analysis using propensity score matching - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - This study sought to compare outcomes of retropubic (RRP), laparoscopic (LRP), and robotic assisted radical prostatectomy (RARP) in a matched fashion with respect to pathological and biochemical outcomes.

EAU 2011 - Cosmetic outcome after radical prostatectomy: A patient’s preference survey - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - The objective of this study was to evaluate patients undergoing laparoscopic or robotic prostatectomy with regards to the psychological effects on self-image as part of the decision-making process.

EAU 2011 - Does the increasing life expectancy translate into decreasing competing mortality rates after radical prostatectomy? - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - As the life expectancy in Eastern Germany was increasing by about 5 years during the time period of this study, the investigators examined whether this translated into lower competing mortality after radical prostatectomy.

EAU 2011 - Is 10-year follow-up long enough to evaluate oncological outcomes of patients after radical prostatectomy? - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - The goal of this study was to evaluate the long-term recurrence rates of patients treated with radical prostatectomy (RP) with a minimum follow-up of 10 years.

EAU 2011 - Prognostic role of histologic subtype in renal cell carcinoma: Results from the SATURN project - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - The knowledge of histological subtypes of kidney cancer and their specific biological behavior has been an important step forward.

EAU 2011 - A prospective randomized trial of hexylaminolevulinate (Hexvix) assisted transurethral resection (TURBT) plus single shot intravesical mitomycin (MMC) versus conventional white light TURBT plus single shot MMC in newly presenting bladder cancer

VIENNA, AUSTRIA (UroToday.com) - The debate about photodynamic diagnosis as well early single shot chemotherapy following TUR as is ongoing.

EAU 2011 - Phase III study of intermittent MAB vs. continuous MAB - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - The investigators presented long term follow up on use of intermittent hormonal therapy vs. continuous therapy for the treatment of advanced prostate cancer.

EAU 2011 - Risk patterns of fractures and cardiovascular and thromboembolic disease, following prostate cancer treatment: Results from the population-based PCBaSe Sweden - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Androgen deprivation therapy (ADT) increases prostate cancer (CaP) patients’ risks for fractures, cardiovascular, and thromboembolic disease (CVD and TED).

EAU 2011 - Association between the extent of pelvic lymphadenectomy and cancer-specific survival in patients with lymph node negative urothelial carcinoma of the bladder undergoing radical cystectomy - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Number of removed lymph nodes and lymphovascular invasion are known predictive parameters of outcome following radical cystectomy for urothelial cancer.

EAU 2011 - Prostate cancer incidence and disease-specific survival in men participating in the ERSPC with an initial PSA under 3.0 ng/ml - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - The ERSPC (European Randomized Study of Screening for Prostate Cancer) uses a prostate-specific antigen (PSA) cut-off ≥3.0 ng/ml as an indication for prostate biopsy.

EAU 2011 - Prostate cancer screening: Can it be improved with total testosterone levels? - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - There is controversy whether prostate cancer (CaP) has altered testosterone or testosterone derivatives.

EAU 2011 - Monolateral nerve sparing prostatectomy: Review of indications, functional and oncological outcomes - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - This study was undertaken to determine surgical candidates for unilateral nerve sparing prostatectomy (URP) and evaluate the oncological and functional results.

EAU 2011 - Oncological outcomes of high-intensity focused ultrasound for localized prostate cancer in 880 consecutive patients - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Dr. Sebastian Crouzet, in collaboration with French colleagues, reviewed patients who underwent HIFU as primary treatment localized prostate cancer (CaP).

EAU 2011 - Race and treatment choice affect cancer specific and overall survival differently in 16,508 men with localized prostate cancer treated in Cancer Research Networks in the United States - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Patients with localized prostate cancer (CaP) were treated either conservatively or by radiotherapy or radical prostatectomy.

EAU 2011 - The role of intraoperative frozen section analysis in bilateral nerve-sparing robot-assisted laparoscopic radical prostatectomy for clinically localized prostate cancer - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - This group from Italy investigated whether use of intraoperative frozen section (IFS) analysis decreases the positive surgical margin (PSMs) rate in patients with clinically localized prostate cancer (CaP) who underwent a bilateral nerve-sparing robotic assisted radical prostatectomy (RALP).

EAU 2011 - Risk assessment of patients who present with asymptomatic hematuria: Development and validation of a nomogram for prediction of bladder cancer presence - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Work-up of hematuria should be standardized because a relevant number of patients will have bladder cancer.

EAU 2011 - More extensive pelvic lymph node dissection is associated with reduced risk of cancer progression in node negative organ confined prostate cancer patients - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Previously, Dr. Urs Studer has reported that an extended pelvic lymph node dissection for prostate cancer (CaP) is associated with better oncologic outcomes, even when the nodes are pathologically negative.

EAU 2011 - Pelvic lymph node dissection (PLND) is performed less frequently in patients treated with minimally invasive radical prostatectomy (MIRP) - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - While PLND provides staging and possibly therapeutic benefit, it is unknown whether it is performed as commonly in patients undergoing MIRP.

Page 586 of 588

Login